medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 1

<< Back Next >>

Med Int Mex 2015; 31 (1)

Candida urinary tract infections. An open study in 29 cases in a general hospital

Vega-Sánchez DC, Bernal-López LE, Villanueva-Recillas S, Arenas GR
Full text How to cite this article

Language: Spanish
References: 11
Page: 19-24
PDF size: 436.36 Kb.


Key words:

urinary tract infection, Candida albicans, diabetes mellitus, nosocomial infection.

ABSTRACT

Background: Candidiasis is caused by Candida spp. Clinical manifestations are related to the immune response of the host; 11% of urinary tract infections are caused by Candida sp and the urinary catheter is the main risk factor for the renal involvement by hematogenous spread. Clinical manifestations are similar to bacterial infections, characterized by malaise, fever, abdominal and low back pain. Renal failure is a complication secondary to the obstruction of the urinary tract by fungal material, with subsequent anuria (urine output ‹50mL/day) and renal failure.
Objective: To identify Candida urinary infections in hospitalized patients, as well as the most common predisposing factor for this comorbidity at General Hospital Dr. Manuel Gea Gonzalez, Mexico City.
Material and method: A retrospective, cross-sectional and observational study was performed in 55 hospitalized patients with urinary infection due to Candida spp.
Results: Just 29 patients were included, because complete data was not available in 26. We isolated Candida spp in 29 patients. Species were distributed as follows: Candida spp (n=15), Candida albicans (n=11), Candida tropicalis (n=2) and Candida parapsilosis (n=1). Patients under prolonged antimicrobial treatment were: with monotherapy (n=6), dual therapy (n=3), triple therapy (n=6), quadruple therapy (n=4). The comorbidities were: diabetes mellitus (n=9), chronic renal failure (n=3), arterial hypertension (n=3), malignancy (n=1), cardiovascular disease (n=1), infections (n=3), none (n=8). Surgical procedure: n=16; Foley catheter user: n=22.
Conclusions: Candida albicans remains one of the most common species in urinary infections, most often in women older than 65 years and the most important associated comorbidity is type 2 diabetes.


REFERENCES

  1. Fisher JF, Kavanagh K, Sobel JD, Kauffman CA, Newman CA. Candida urinary tract infection: pathogenesis. Clin Infect Dis 2011;52:437-451.

  2. Bukhary ZA. Candiduria: a review of clinical significance and management. Saudi J Kidney Dis Transpl 2008;19:350-360.

  3. Arenas R. Atlas Dermatología. Diagnóstico y tratamiento. 5a ed. México: Mc Graw-Hill, 2014;240-260.

  4. Kauffman CA. Diagnosis and management of fungal urinary tract infection. Infect Dis Clin North Am 2014;28:61-74.

  5. Bouza E, San Juan R, Muñoz P, et al, Co-operative Group of the European Study Group on Nosocomial Infections. A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect 2001;7:523-531.

  6. Fisher JF, Sobel JD, Kauffman CA. Candida urinary tract infections and treatment. Clin Infect Dis 2011;52:457-466.

  7. Yismaw G, Asrat D, Woldeamanuel Y, Unaka C. Prevalence of candiduria in diabetic patients attending Gondar University Hospital, Gondar, Ethiopia. Iran J Kidney Dis 2013;7:102.

  8. Kauffman CA. Candiduria. Clin Infect Dis 2005:41:371-376.

  9. Wise GJ, Kozinn PJ, Goldberg P. Amphotericin B as a urologic irrigant in the management of noninvasive candiduria. J Urol 1982;128:82-84.

  10. Pappas PG, Kauffman CA, Andes D, Benjamin DK, et al. Clinical Practice Guidelines for the Management of Candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;48:503-535.

  11. Sobel JD, Bradshaw SK, Lipka CJ, Kartsonis NA. Caspofungin in the treatment of symptomatic candiduria. Clin Infect Dis 2007;44-46.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2015;31